Ketodex

PreclinicalSmall molecule

GGiresun University

Ketodex is one of 3 small molecule programs targeting Hemodynamic Response. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Hemodynamic ResponseNot yet recruiting

Hemodynamic ResponsePreclinical

Not yet recruiting

Competition

Competitive Landscape

2 competitors in Hemodynamic Response

#DrugCompanyPhaseTrials

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

11 2

Ketofol

TTanta University

Preclinical

1 3

Ketodex

GGiresun University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2028

PreclinicalNot yet recruiting

Hemodynamic Response

NCT07783256

Clinical

Trials by Indication[1]

Hemodynamic Response1 trial

Effectiveness of Intravenous Ketodex Versus Ketofol for Obtunding Hemodynamic Responses to Laryngoscopy and Tracheal Intubation in Adult Elective Middle Ear Surgery Patients: A Prospective Randomized Comparative Study

Not yet recruiting·AAssiut University·Preclinical·NCT07783256·70 enrolled

Procedural Sedation1 trial

The Effect of Anesthesia Protocols Used in Gastrointestinal Endoscopy Procedures in Adolescents on the Outcome

Completed·GGiresun University··NCT07401914·90 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Ketodex. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ketodex compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ketodex. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Giresun University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: GGiresun University

Ketodex

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2028

Trials by Indication[1]

Hemodynamic Response1 trial

Procedural Sedation1 trial

References

Drug Info

Quick Facts

Related News